Rosen Law Firm Announces Lead Plaintiff Opportunity in Insulet Corporation Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, has alerted investors who purchased securities of Insulet Corporation (NASDAQ: PODD) during a specified class period to an upcoming deadline to seek appointment as lead plaintiff. The deadline for potential lead plaintiffs to file with the Court is August 31, 2026. Investors may be eligible for compensation without incurring out-of-pocket expenses through a contingency fee arrangement.

The class action lawsuit alleges that Insulet Corporation and its executives made false and misleading statements and failed to disclose critical information regarding the company's operations. Specifically, the suit claims that defendants failed to disclose defective manufacturing controls and procedures. According to the complaint, these deficiencies created a foreseeable heightened risk of product non-compliance with safety regulations or injury, causing damages to investors when the true details emerged.

The lawsuit covers purchasers of Insulet Corporation securities between February 21, 2025, and May 26, 2026, inclusive. Rosen Law Firm, which specializes in securities class actions, is encouraging investors to select counsel with experience in leading such litigation. The firm has provided contact information for those seeking more details about the class action.

Investors are reminded that no class has been certified yet, and they are not represented by counsel unless they retain their own. An investor's ability to share in any potential recovery is not dependent on serving as lead plaintiff.